Erythropoietin in the Prevention of Acute Mountain Sickness

NCT01665781 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Acute Mountain Sickness

Interventions

DRUG: Erythropoietin

Sponsor

University of Ulsan

Collaborators

[object Object]